AKT1 and metabolic disease: Importantly, PIPs play key roles in the PI3K/AKT insulin signaling pathway and glucose and lipid metabolism; dysregulation of these signaling pathways is associated with various metabolic diseases, including diabetes, obesity, inflammatory conditions, and cardiovascular disease.